.
Rheumatology (Pathology Clinical Pharmacology Methods of Examination and Interpretation of Data, Symptomatology and Pharmacotherapy)
Study Course Description
Course Description Statuss:Approved
Course Description Version:4.00
Study Course Accepted:21.03.2024 09:23:48
| Study Course Information | |||||||||
| Course Code: | ISK_053 | LQF level: | Level 7 | ||||||
| Credit Points: | 1.00 | ECTS: | 1.50 | ||||||
| Branch of Science: | Basic Sciences of Medicine, including Pharmacy | Target Audience: | Clinical Pharmacy | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Larisa Umnova | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Department of Internal Diseases | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Riga, 2 Hipokrata Street, isk rsu[pnkts]lv, +371 67042338 | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 3 | Lecture Length (academic hours) | 3 | Total Contact Hours of Lectures | 9 | ||||
| Classes (count) | 1 | Class Length (academic hours) | 3 | Total Contact Hours of Classes | 3 | ||||
| Total Contact Hours | 12 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Human anatomy, physiology and pathology, medical biochemistry, pharmacology. | ||||||||
| Objective: | To provide students with knowledge in clinical areas – pathophysiology of diseases, clinical manifestations of rheumatological diseases, evaluation of examinations, basic methods of treatment and pharmacotherapy options for rheumatological diseases. The study module comprises an integrated training cycle in which the student is gradually introduced to the pathological physiology of a group of diseases, clinical pharmacology, clinical manifestations, examination possibilities, interpretation of examination data, principles of treatment and pharmacotherapy possibilities. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Rheumatological pathologies. | Lectures | 1.00 | auditorium | |||||
| 2 | Clinical pharmacology in rheumatology. | Lectures | 1.00 | auditorium | |||||
| 3 | Differential diagnosis and principles of treatment of diseases of the musculoskeletal and articular systems. | Lectures | 1.00 | clinical base | |||||
| 4 | Rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, systemic scleroderma, vasculitis: epidemiology, causes, clinical manifestations, diagnosis, treatment tactics and prevention. | Classes | 1.00 | clinical base | |||||
| Assessment | |||||||||
| Unaided Work: | The student independently studies the literature offered in the study programme, summarises the obtained information. Prepares a clinical pharmacist’s assessment of pharmacotherapy for a patient with a rheumatological condition. | ||||||||
| Assessment Criteria: | Active participation in practical classes; written assignments completed in high quality and submitted on time, quality of oral answers. Exam: understanding of the principles of diagnosis and treatment of internal diseases, including clinical case analysis, is tested. | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | As a result of successfully completing the course, the student will have knowledge of the following: • aetiology, pathogenesis of rheumatological diseases; • the most common clinical manifestations and complications of rheumatological diseases; • evaluation of the results of diagnostic examinations for rheumatological diseases; • basic treatments for rheumatological diseases; • pharmacotherapy options for rheumatological diseases. | ||||||||
| Skills: | The student will be able: • to assess and interpret the results of diagnostic examinations for rheumatological diseases; • to assess the pharmacotherapy of rheumatological diseases. | ||||||||
| Competencies: | The student will be able: • in collaboration with the medical practitioners, to determine a pharmacotherapy plan for the individual rheumatology patient; • to assess the advantages and disadvantages of pharmacotherapy methods in relation to the patient’s examination data; • to monitor the progress of pharmacotherapy, predict side effect and plan the prevention thereof, and provide the necessary information to other medical specialists. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | A. Lejnieka redakcijā. Klīniskā medicīna. Trešā grāmata. Rīga, Medicīnas apgāds, 2012 (akceptējams izdevums) | ||||||||
| 2 | G. Firestein, R. Budd, E. Harris, I. McInnes, S. Ruddy, J. Sergent, eds. Firestein & Kelley's Textbook of Rheumatology, 11th Edition. Philadelphia, PA: W.B. Saunders Company, 2021 | ||||||||
| 3 | Lekciju un nodarbību materiāli. | ||||||||
| Additional Reading | |||||||||
| 1 | Bates Guide to Physical Examination and History Taking. 12th edition. Lippincott Williams &Wilkins, 2017 | ||||||||
| 2 | Goldman-Cecil Medicine. W.B.Saunders Company, Philadelphia, 2020 | ||||||||
| Other Information Sources | |||||||||
| 1 | The Merck Manual, Internets | ||||||||
| 2 | http://www.merck.com/mrkshared/manual/home.jsp | ||||||||
